Product Category menu

Category background

Pharmaceutical Paclitaxels for Lung Ovarian Breast Cancer

Product Detail Information
Product Description
 
Factory High Quality Raw Powder Pre-Paclitaxels for Anticancer Treatment (33069-62-4)
Quick Detail:
EINECS No.:  33069-62-4
MF:  C47H51NO14
MW: 853.92
Purity:  99%  
Packaging Detail: 200kg/drum or as your require 
Boiling point:    137 °C
Melting point:    82-87 °C
Flash point:     50 °C
Solubility: soluble in water, ethanol, acetone and most of the non-volatile oil.

Description:

Paclitaxels is a drug used to treat ovarian, breast, lung, pancreatic and other cancers.

Medical use:

Paclitaxels is approved in the UK for ovarian, breast and lung, bladder, prostate, melanoma, esophageal, and other types of solid tumor cancers as well as Kaposi's sarcoma.[5] It is recommended in NICE guidance of June 2001 that it should be used for nonsmall cell lung cancer in patients unsuitable for curative treatment, and in first-line and second-line treatment of ovarian cancer. In September 2001, NICE recommended Paclitaxels should be available for the treatment of advanced breast cancer after the failure of anthracyclic chemotherapy, but that its first-line use should be limited to clinical trials. In September 2006, NICE recommended Paclitaxels should not be used in the adjuvant treatment of early node-positive breast cancer.[6] In 2005, its use in the United States for the treatment of breast, pancreatic, and non-small cell lung cancers was approved by the FDA.

 


Related EGFR Products :
Erlotinib CAS: 183321-74-6 
Afatinib (BIBW2992) Dimaleate CAS: 850140-73-7 
Poziotinib (HM781-36B) CAS: 1092364-38-9 
Gefitinib (ZD1839) CAS: 184475-35-2 
Erlotinib HCl (OSI-744) CAS: 183319-69-9 
Afatinib (BIBW2992) CAS: 439081-18-2 
Osimertinib (AZD9291) CAS: 1421373-66-1 
Lapatinib CAS: 231277-92-2 
AG-490 (Tyrphostin B42) CAS: 133550-30-8 / CAS: 134036-52-5 
Rociletinib (CO-1686, AVL-301) CAS: 1374640-70-6 
Olaparib (AZD2281, Ku-0059436) CAS: 763113-22-0 
Trametinib (GSK1120212) CAS: 871700-17-3 
Bortezomib (PS-341) CAS: 179324-69-7 
Ipatasertib (GDC-0068) CAS: 1001264-89-6 
Ibrutinib (PCI-32765) CAS: 936563-96-1 
Poziotinib (HM781-36B) CAS: 1092364-38-9